U
Navidea Biopharmaceuticals, Inc. NAVB
$0.0001 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2023 06/30/2023 03/31/2023 12/31/2022 09/30/2022
Net Income -- 301.09% 50.58% 4.64% -134.14%
Total Depreciation and Amortization -- 24.31% 20.52% 24.41% 36.46%
Total Amortization of Deferred Charges -- 87.19% -- -- --
Total Other Non-Cash Items -- 75.38% -445.71% -9.84% -43.63%
Change in Net Operating Assets -- -337.01% 911.02% 10.41% 1,549.12%
Cash from Operations -- 319.25% 32.63% 10.82% 7.67%
Capital Expenditure -- 100.00% 64.05% 100.00% 20.00%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- 43.02% 68.11% 15.29% 44.01%
Cash from Investing -- 46.37% 66.67% 19.46% 40.77%
Total Debt Issued -- -80.00% -- -- --
Total Debt Repaid -- -342.54% 40.94% 42.39% --
Issuance of Common Stock -- -- -- -100.00% --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- 179.61%
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -273.97% -- -- --
Cash from Financing -- 8.25% 40.94% 21.73% 181.27%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -- 787.22% 34.90% 11.56% 6,780.52%
Weiss Ratings